Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
04/2003
04/16/2003CN1410094A Ointment for treating nuchal rigidity
04/16/2003CN1410087A Pain eliminating liquor No.1
04/16/2003CN1410081A Capsule for treating rheumatism, rheumatoid archritis
04/16/2003CN1410066A Ursolic acid poly lactic acid nano particle freeze dried powder for ampoule agent and its preparation method
04/16/2003CN1410065A Ursolic acid cyano acrylic ester nano particle freeze dried powder for ampoule agent and its preparation method
04/16/2003CN1410064A Ursolic acid bean phospholipid nano particle freeze drying powder for ampoule agent and its preparation method
04/16/2003CN1410054A II type collagen water soluble dispersion composition, its preparation method and application
04/16/2003CN1105723C Spirocyclic metalloprotease inhibitors
04/16/2003CN1105706C Cyclic amidino agents useful as nitric oxide synthase inhibitors
04/16/2003CN1105705C Process for preparing heterocyclic amide derivative with specific physical status
04/16/2003CN1105574C Therapeutic uses of bactericidal/permeability increasing protein products
04/16/2003CN1105570C Medicinal composition for curing arthritis and osteoarth ropathy and its preparing method
04/16/2003CN1105564C Medicine for warming kidney and treating wind-dampness syndrome and preparation process thereof
04/15/2003US6548715 Which lacks the combined presence of the trans-fused ring; increased therapeutic potential; for cell proliferation; veterinary medicine
04/15/2003US6548699 4,4*-(Isopropylidenedithio)-(2*,6*-di-tert-butylphenol)-(2,6-d i-tert-butylphenol-O*-acetic acid); antiarthritic, antiinflammatory agents; rheumatic and cardiovascular disorders
04/15/2003US6548694 N-(4-carbamimidoyl-phenyl)-glycine derivatives
04/15/2003US6548671 Quinoxalinyl amide derivatives
04/15/2003US6548668 Stabilizer for proteins
04/15/2003US6548667 For prevention and treatment of diseases caused by overexpression and overactivation of matrix metalloproteinase
04/15/2003US6548540 Administering dithiocarbamate thiolate anions to sensitize humans to conventional chemotherapy by blocking the p-glycoprotein membrane toxin extrusion pump
04/15/2003US6548533 Pyrrolidine carboxylic Acid or ester derivatives are useful for treating alpha 4 beta 1 mediated cell adhesion
04/15/2003US6548520 Substituted imidazoles having anti-cancer and cytokine inhibitory activity
04/15/2003US6548514 Inhibitors of p38 kinase/cytokine suppressive binding protein (CSBP)/reactivating kinase (RK); 1-((pyridyl)aminocarbonyl)-3-((hetero)arylaminocarbonyl)benzene derivatives; treating cytokine related diseases and disorders
04/15/2003US6548507 Use of sodium channel antagonists in the treatment of diseases mediated or exacerbated by neuronal apoptosis, such as multiple sclerosis; administering drugs such as lamotrigine
04/15/2003US6548503 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines
04/15/2003US6548500 Treating a cell adhesion-mediated diseases such as multiple sclerosis, asthma, atherosclerosis, rheumatoid arthritis, meningitis, comprising administering to a warm blooded animal a nitrogen atoms containing bicyclic compound
04/15/2003US6548498 Substituted indan derivatives
04/15/2003US6548497 Methods of reducing non-inflammatory pain
04/15/2003US6548494 3,4-dihydro-2H-(1,4)diazepino(6,7,1-hi)indol-1-one or 1-thione derivatives where indole C3 could also be N; use treating cancers as well as stroke, head trauma, and neurodegenerative diseases
04/15/2003US6548483 Nutritional preparation comprising ribose and medical use thereof
04/15/2003US6548479 Fused bicyclic peptides are administered to an animal to inhibit the proliferation of CD4 T-cells
04/15/2003US6548279 For polypeptides able to catalyze the enzymatic function of superoxide dismutase, carbonic anhydrase, or HIV protease
04/15/2003US6548270 An expression vector comprising a recombinant polynucleotide encoding a protein containing specific amino acid sequence; genetic engineering
04/15/2003CA2278988C An efficient synthesis of furan sulfonamide compounds useful in the synthesis of new il-1 inhibitors
04/15/2003CA2099588C Prevention of synovial adhesions
04/15/2003CA2078466C Novel 3-cycloalkyl-propen-2-amide derivatives, tautomers and salts thereof, process for preparing the same and their use as drugs, compositions containing them
04/15/2003CA2053208C Hydroxyalkylquinoline ether acids as leukotriene antagonists
04/15/2003CA2051504C 1-phenyl-3-aryl-2-propyne-1-ones as calcium uptake inhibitors
04/15/2003CA2037975C 5-hydroxy-2,3-dihydrobenzofuran analogs as leukotriene biosynthesis inhibitors
04/11/2003WO2002030934A1 Substituted 3.4-dihydro-pyrimido[1,2-a]pyrimidines and 3.4-dihydropyrazino[1,2-a]pyrimidines
04/11/2003WO2002030872A1 Novel aliphatic compounds, process for their preparation and their usage
04/11/2003CA2425923A1 Novel aliphatic compounds, process for their preparation and their usage
04/11/2003CA2425685A1 Substituted 3.4-dihydro-pyrimido[1,2-a]pyrimidines and 3.4-dihydropyrazino[1,2-a]pyrimidines
04/10/2003WO2003029824A1 Method and agent for diagnosing and treating chronic inflammatory bowel diseases
04/10/2003WO2003029437A2 Secreted proteins
04/10/2003WO2003029410A2 METHODS OF USING 69039, A NOVEL HUMAN Na/Ca EXCHANGER FAMILY MEMBER
04/10/2003WO2003029295A1 Human tissue factor antibodies
04/10/2003WO2003029293A2 Modulators of notch ic protease activity for use in immunotherapy
04/10/2003WO2003029276A2 Copolymers for suppression of autoimmune diseases, and methods of use
04/10/2003WO2003029264A2 2-propynyl adenosine analogs having a2a agonist activity and compositions thereof
04/10/2003WO2003029252A1 Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
04/10/2003WO2003029245A1 Spiro-hydantoin compounds useful as anti-inflammatory agents
04/10/2003WO2003029244A1 Process for preparing pyridyl-alkylsulfonyl pyrazole derivatives
04/10/2003WO2003029242A1 NF-λB INHIBITORS
04/10/2003WO2003029221A1 Tetrahydroisochinolines, their production and the use thereof as analgesics
04/10/2003WO2003029218A1 Novel nitrogenous compound and use thereof
04/10/2003WO2003029217A2 Pyridinic sulfonamide derivatives, method of production and use thereof
04/10/2003WO2003029212A1 Indole derivatives as cox ii inhibitors
04/10/2003WO2003029210A2 Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5
04/10/2003WO2003029205A1 Diaryl sulfide derivative, addition salt thereof, and immunosuppressant
04/10/2003WO2003029200A2 Compounds useful as reversible inhibitors of cysteine proteases
04/10/2003WO2003029187A1 Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them
04/10/2003WO2003029185A1 Novel compounds
04/10/2003WO2003029184A1 Diaryl ether derivative, addition salt thereof, and immunosuppressant
04/10/2003WO2003029176A1 4-(c2-6alkoxy)-substituted chalcones as therapeutic agents
04/10/2003WO2003028990A1 Systems, methods and apparatuses for manufacturing dosage forms
04/10/2003WO2003028989A1 Systems, methods and apparatuses for manufacturing dosage forms
04/10/2003WO2003028749A1 Matrix metalloprotease inhibitor
04/10/2003WO2003028746A1 Method for producing extracts of pelargonium sidoides and/or pelargonium reniforme, and the use of said extracts
04/10/2003WO2003028705A1 Pharmaceutical compositions comprising colloidal silicon dioxide
04/10/2003WO2003028702A1 Ibuprofen salt emulsifiers and cream formulations containing same
04/10/2003WO2003028696A2 Compositions for delivery of drug combinations
04/10/2003WO2003028692A2 Acne treatment using oleanolic acid
04/10/2003WO2003028662A2 A method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same
04/10/2003WO2003028630A2 Methods and compositions for modulating interleukin-21 receptor activity
04/10/2003WO2003028590A1 Rational drug therapy device and methods
04/10/2003WO2003017935A9 Human antibodies specific for interleukin 15 (il-15)
04/10/2003WO2003007971A9 Improved heteropolymer complexes and methods for their use
04/10/2003WO2003000709A9 Sialic acid derivatives for use as siglec inhibitors
04/10/2003WO2002102768A3 Regulation of neuronal function through metabotropic glutamate receptor signaling pathways
04/10/2003WO2002094203A3 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
04/10/2003WO2002092064A3 Therapeutic method for inducing tolerance
04/10/2003WO2002083105A3 Composition for enhanced absorption of nsaids
04/10/2003WO2002083103A3 Pharmaceutical product with reticulated crystalline microstructure
04/10/2003WO2002081668A8 Desaturase genes and uses thereof
04/10/2003WO2002071827A3 Retinoid x receptor modulators
04/10/2003WO2002059083A3 Novel compounds
04/10/2003WO2002057460A3 Polynucleotides encoding human phosphatases
04/10/2003WO2002045687A3 Topical alcoholic solution of a salicylic acid derivative and acemannan
04/10/2003WO2002040666A3 Fat regulated genes, uses thereof, and compounds for modulating same
04/10/2003WO2002008396A3 Human proteases
04/10/2003US20030069435 Prevention of neutrophil recruitment
04/10/2003US20030069430 Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effects
04/10/2003US20030069428 Pharmaceutically active isoindoline derivatives
04/10/2003US20030069425 Substituted pyrimidine compounds and methods of use
04/10/2003US20030069424 Indolylmaleimide derivatives
04/10/2003US20030069406 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of blood disorders
04/10/2003US20030069393 Compound for use in the treatment of cancer and prevention of infections
04/10/2003US20030069316 Use of comt inhibitors as analgesics
04/10/2003US20030069311 N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity